Adrienne Monson – Lifestyle
Author:
Sanofi Winthrop Industrie
Press Release: Sanofi’s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
April 22, 2026
Press Release: Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the US
April 22, 2026
Press Release: ESCMID: Sanofi’s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
April 18, 2026
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
April 13, 2026
Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
April 7, 2026
Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
March 31, 2026
Press Release: AAD: new results from Sanofi’s amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
March 30, 2026
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
March 27, 2026
Press release: Availability of the Q1 2026 aide-mémoire
March 24, 2026
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
March 24, 2026
1
2
Next Page
→